Randomized trial of vitamin D3 to prevent worsening of musculoskeletal symptoms in women with breast cancer receiving adjuvant letrozole. The VITAL trial

Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial

M Baum, Aman U. Budzar, J Cuzick et al. · The Lancet · 2002 · 2K citations

Pharmacy, Oncology, Pharmacotherapy +13

A Randomized Trial of Exemestane after Two to Three Years of Tamoxifen Therapy in Postmenopausal Women with Primary Breast Cancer

R. Charles Coombes, Emma Hall, Lorna J. Gibson et al. · New England Journal of Medicine · 2004 · 1.8K citations · Full text

Pharmacy, Endocrinology, Oncology +13

Five Years of Letrozole Compared With Tamoxifen As Initial Adjuvant Therapy for Postmenopausal Women With Endocrine-Responsive Early Breast Cancer: Update of Study BIG 1-98

Alan S. Coates, Aparna Keshaviah, Beat Thürlimann et al. · Journal of Clinical Oncology · 2007 · 904 citations

Medicine, Oncology, Breast Oncology +13

Prevalence of Severe Hypovitaminosis D in Patients With Persistent, Nonspecific Musculoskeletal Pain

Gregory A. Plotnikoff, Joanna Quigley · Mayo Clinic Proceedings · 2003 · 693 citations

Medicine, Orthopedic Surgery, Musculoskeletal Medicine +12

Prevalence of Joint Symptoms in Postmenopausal Women Taking Aromatase Inhibitors for Early-Stage Breast Cancer

Katherine D. Crew, Heather Greenlee, Jillian L. Capodice et al. · Journal of Clinical Oncology · 2007 · 481 citations

Medicine, Oncology, Breast Oncology +14